A review of medical marijuana for the treatment of posttraumatic stress disorder: Real symptom re-leaf or just high hopes?. Shishko, I., Oliveira, R., Moore, T., A., & Almeida, K. Mental Health Clinician, 8(2):86-94, College of Psychiatric & Neurologic Pharmacists, 3, 2018.
A review of medical marijuana for the treatment of posttraumatic stress disorder: Real symptom re-leaf or just high hopes? [link]Website  abstract   bibtex   
Abstract Introduction: The incidence of posttraumatic stress disorder (PTSD) is common within the population and even more so among veterans. Current medication treatment is limited primarily to antidepressants. Such medicines have shown to produce low remission rates and may require 9 patients to be treated for 1 to have a response. Aside from the Veterans Affairs/Department of Defense guidelines, other guidelines do not recommend pharmacotherapy as a first-line option, particularly in the veteran population. Marijuana has been evaluated as an alternative and novel treatment option with 16 states legalizing its use for PTSD. Methods: A systematic search was conducted to evaluate the evidence for the use of marijuana for PTSD. Studies for the review were included based on a literature search from Ovid MEDLINE and Google Scholar. Results: Five studies were identified that evaluated the use of marijuana for PTSD. One trial was conducted in Israel and actively used marijuana. Three studies did not use mariju...
@article{
 title = {A review of medical marijuana for the treatment of posttraumatic stress disorder: Real symptom re-leaf or just high hopes?},
 type = {article},
 year = {2018},
 identifiers = {[object Object]},
 pages = {86-94},
 volume = {8},
 websites = {http://mhc.cpnp.org/doi/10.9740/mhc.2018.03.086},
 month = {3},
 publisher = {College of Psychiatric & Neurologic Pharmacists},
 day = {26},
 id = {3afc3dd8-cb8c-3acb-be73-c4391ece0745},
 created = {2018-03-03T20:06:36.343Z},
 accessed = {2018-03-03},
 file_attached = {false},
 profile_id = {48f1fda5-0084-39cd-8cc7-68fcbd29ae85},
 group_id = {d9389c6c-8ab5-3b8b-86ed-33db09ca0198},
 last_modified = {2018-05-31T16:53:50.731Z},
 tags = {OA},
 read = {false},
 starred = {false},
 authored = {false},
 confirmed = {true},
 hidden = {false},
 citation_key = {Shishko2018},
 private_publication = {false},
 abstract = {Abstract Introduction: The incidence of posttraumatic stress disorder (PTSD) is common within the population and even more so among veterans. Current medication treatment is limited primarily to antidepressants. Such medicines have shown to produce low remission rates and may require 9 patients to be treated for 1 to have a response. Aside from the Veterans Affairs/Department of Defense guidelines, other guidelines do not recommend pharmacotherapy as a first-line option, particularly in the veteran population. Marijuana has been evaluated as an alternative and novel treatment option with 16 states legalizing its use for PTSD. Methods: A systematic search was conducted to evaluate the evidence for the use of marijuana for PTSD. Studies for the review were included based on a literature search from Ovid MEDLINE and Google Scholar. Results: Five studies were identified that evaluated the use of marijuana for PTSD. One trial was conducted in Israel and actively used marijuana. Three studies did not use mariju...},
 bibtype = {article},
 author = {Shishko, Ilona and Oliveira, Rosana and Moore, Troy A. and Almeida, Kenneth},
 journal = {Mental Health Clinician},
 number = {2}
}

Downloads: 0